US CDC Recommends Expanding Pneumococcal Vaccines to Adults Aged 50-64
The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease. The agency's earlier recommendation for vaccination was for adults 65 years or older and children younger than 5,
As the weather starts to cool down and we spend more time gathered together indoors, the risk of contracting an illness rises ...
As winter approaches, the Centers for Disease Control and Prevention (CDC) has updated its guidelines to help reduce the ...
The AHA Oct. 24 announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention ...
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
Marine, not her real name, was considering surgery to deal with intense pain. Three doctors refused to see her before a ...
MRSA is a type of staph bacteria that commonly lives on the skin and is resistant to many often used antibiotics. Learn about ...
Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle ...
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback